KDR and cancer: Understanding the mechanisms involved in angiogenesis and the discovery that vascular endothelial growth factor (VEGF) appeared to have a central role has led to the development of anti-VEGF and anti-VEGF receptor (VEGFR) antibodies as anticancer agents, which have been used with varying degrees of success for the treatment of some cancers [33].